Company intelligence / Profile preview

Diamond Biofund

Taipei, Taipei City, Taiwandiamondbiofund.com ↗

Ownership: Private
Employees: ~33
Development stage: Commercial

Overview

Diamond Biofund is a leading Taiwan-based venture capital firm focused on early-stage investments in biotechnology, pharmaceuticals, high-end medical equipment, innovative medical services/channels, and agricultural biotechnology. It does not develop drugs or devices itself but funds startups and early ventures across these sectors. The company is publicly listed on the Taiwan Stock Exchange under ticker 6901.

Modalities: Small moleculeBiologicMedical device
Industry: Investors

Drug pipeline

5 assets

ChemoYoung

Commercial

Indications: Chemotherapy-induced fatigue, Chemotherapy-induced appetite loss

4 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Diamond Biofund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Diamond Biofund.

Explore the full profile